Skip to main content
Veterinary Medicines

Revertor 5 mg/ml Solution for Injection for Dogs and Cats

Authorised
  • Atipamezole hydrochloride

Product identification

Medicine name:
Revertor 5 mg/ml Solution for Injection for Dogs and Cats
Revertor 5 mg/ml Solution for Injection for Dogs and Cats
Active substance:
  • Atipamezole hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Atipamezole hydrochloride
    5.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QV03AB90
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • (ID3) 100 millilitre(s): unspecified outer container with 10 Vial each with 10 millilitre(s)
  • (ID2) 50 millilitre(s): unspecified outer container with 5 Vial each with 10 millilitre(s)
  • (ID1) 10 millilitre(s): unspecified outer container with 1 Vial with 10 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cp-Pharma Handelsgesellschaft mbH
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10810/004/001
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0123/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • France
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."